US20210003580A1
University of Texas System
Described here are methods of treatment of hyper transcription diseases in patients by administering a combination of an inhibitor of Ataxia Telangiectasia and Rad3 related Serine/Threonine protein kinase and an inhibitor of poly (ADP-ribose) polymerase (1). Described here are methods of treatment …